|
|
Prepublished online as a Blood First Edition Paper on December 27, 2002; DOI 10.1182/blood-2002-05-1341.
Previous Article | Table of Contents | Next Article 
Blood, 15 April 2003, Vol. 101, No. 8, pp. 2973-2982
HEMATOPOIESIS
Fetal liver stroma consists of cells in epithelial-to-mesenchymal
transition
Jalila Chagraoui,
Adeline Lepage-Noll,
Aurora Anjo,
Georges Uzan, and
Pierre Charbord
From INSERM U506, Hôpital Paul Brousse,
Villejuif, France; Laboratoire de Microscopie Electronique du service
d'Anatomopathologie, Hôpital Paul Brousse, Villejuif,
France; and Laboratoire
d'Hématopoïèse, Faculté de Médecine,
Tours, France.
Liver becomes the predominant site of hematopoiesis by 11.5 dpc
(days after coitus) in the mouse and 15 gestational weeks in
humans and stays so until the end of gestation. The reason the liver is
the major hematopoietic site during fetal life is not clear. In this
work, we tried to define which of the fetal liver microenvironmental
cell populations would be associated with the development of
hematopoiesis and found that a population of cells with mixed
endodermal and mesodermal features corresponded to
hematopoietic-supportive fetal liver stroma. Stromal cells generated
from primary cultures or stromal lines from mouse or human fetal liver
in the hematopoietic florid phase expressed both mesenchymal markers
(vimentin, osteopontin, collagen I, smooth muscle actin,
thrombospondin-1, EDa fibronectin, calponin, Stro-1 antigens,
myocyte-enhancer factor 2C) and epithelial ( -fetoprotein, cytokeratins 8 and 18, albumin, E-cadherin, hepatocyte nuclear factor 3 ) markers. Such a cell population fits with the description of cells
in epithelial-to-mesenchymal transition (EMT), often observed during
development, including that of the liver. The hematopoietic supportive
capacity of EMT cells was lost after hepatocytic maturation, induced by
oncostatin M in the cell line AFT024. EMT cells were observed in the
fetal liver microenvironment during the hematopoietic phase but not in
nonhematopoietic liver by the end of gestation and in the adult. EMT
cells represent a novel stromal cell type that may be generated from
hepatic endodermal or mesenchymal stem cells or even from circulating
hematopoietic stem cells (HSCs) seeding the liver rudiment.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Kisseleva and D. A. Brenner
Mechanisms of Fibrogenesis
Experimental Biology and Medicine,
February 1, 2008;
233(2):
109 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sato, K. Harada, S. Ozaki, S. Furubo, K. Kizawa, T. Sanzen, M. Yasoshima, H. Ikeda, M. Sasaki, and Y. Nakanuma
Cholangiocytes with Mesenchymal Features Contribute to Progressive Hepatic Fibrosis of the Polycystic Kidney Rat
Am. J. Pathol.,
December 1, 2007;
171(6):
1859 - 1871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Phinney and D. J. Prockop
Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair Current Views
Stem Cells,
November 1, 2007;
25(11):
2896 - 2902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zeisberg, C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
J. Biol. Chem.,
August 10, 2007;
282(32):
23337 - 23347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kaimori, J. Potter, J.-y. Kaimori, C. Wang, E. Mezey, and A. Koteish
Transforming Growth Factor-beta1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro
J. Biol. Chem.,
July 27, 2007;
282(30):
22089 - 22101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech
The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities
Stem Cells,
July 1, 2007;
25(7):
1737 - 1745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kinoshita, Y. Iimuro, K. Otogawa, S. Saika, Y. Inagaki, Y. Nakajima, N. Kawada, J. Fujimoto, S. L Friedman, and K. Ikeda
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats
Gut,
May 1, 2007;
56(5):
706 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chateauvieux, J.-L. Ichante, B. Delorme, V. Frouin, G. Pietu, A. Langonne, N. Gallay, L. Sensebe, M. T. Martin, K. A. Moore, et al.
Molecular profile of mouse stromal mesenchymal stem cells
Physiol Genomics,
April 24, 2007;
29(2):
128 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Sicklick, S. S. Choi, M. Bustamante, S. J. McCall, E. H. Perez, J. Huang, Y.-X. Li, M. Rojkind, and A. M. Diehl
Evidence for epithelial-mesenchymal transitions in adult liver cells
Am J Physiol Gastrointest Liver Physiol,
October 1, 2006;
291(4):
G575 - G583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Y. Dan, K. J. Riehle, C. Lazaro, N. Teoh, J. Haque, J. S. Campbell, and N. Fausto
Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages
PNAS,
June 27, 2006;
103(26):
9912 - 9917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P.S. Monga, M. S. Hout, M. J. Baun, A. Micsenyi, P. Muller, L. Tummalapalli, A. R. Ranade, J.-H. Luo, S. C. Strom, and J. C. Gerlach
Mouse Fetal Liver Cells in Artificial Capillary Beds in Three-Dimensional Four-Compartment Bioreactors
Am. J. Pathol.,
November 1, 2005;
167(5):
1279 - 1292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. CHARBORD and K. MOORE
Gene Expression in Stem Cell-Supporting Stromal Cell Lines
Ann. N.Y. Acad. Sci.,
June 1, 2005;
1044(1):
159 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C.D. van IJzendoorn, D. Theard, J. M. van der Wouden, W. Visser, K. A. Wojtal, and D. Hoekstra
Oncostatin M-stimulated Apical Plasma Membrane Biogenesis Requires p27Kip1-Regulated Cell Cycle Dynamics
Mol. Biol. Cell,
September 1, 2004;
15(9):
4105 - 4114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lanza, M. A.S. Moore, T. Wakayama, A. C.F. Perry, J.-H. Shieh, J. Hendrikx, A. Leri, S. Chimenti, A. Monsen, D. Nurzynska, et al.
Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation
Circ. Res.,
April 2, 2004;
94(6):
820 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yan, T. Devos, L. Yu, G. Xia, O. Rutgeerts, J. Goebels, C. Segers, Y. Lin, M. Vandeputte, and M. Waer
Pathogenesis of Autoimmunity After Xenogeneic Thymus Transplantation
J. Immunol.,
June 15, 2003;
170(12):
5936 - 5946.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |